Recruiting Myelofibrosis Studies in Chicago
About Myelofibrosis Clinical Trials in Chicago
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 1 myelofibrosis clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 385 participants. Research is being sponsored by Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Chicago — FAQ
Are there myelofibrosis clinical trials in Chicago?
Yes, there are 1 myelofibrosis clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 1 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov